Credit Suisse »

Halozyme Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2013-03-31 $1.6M 277k 5.76
2012-09-30 $539k 71k 7.55
2011-09-30 $757k 124k 6.13
2011-06-30 $977k 141k 6.91
2011-03-31 $660k 98k 6.71
2010-12-31 $724k 91k 7.92